Clinical Trial Update: Adjuvant IMRT With Concommitant Raltitrexed Chemotherapy for Locally Advanced Gastric Cancer After D0/D1 Radical Resection [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating adjuvant IMRT with concurrent raltitrexed chemotherapy after D0/D1 gastric cancer resection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Raltitrexed (Raltitrexed)

Snippet

Sponsor: Zhongnan Hospital | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN